Hepatitis B immune globulin - SK Chemicals

Drug Profile

Hepatitis B immune globulin - SK Chemicals

Alternative Names: HBIG; Hepabulin Antibody injection; Hepabulin IV; IV Hepabulin SN

Latest Information Update: 20 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SK Chemicals
  • Developer SK Chemicals; SK Plasma
  • Class Antivirals; Immunoglobulins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Hepatitis B

Most Recent Events

  • 24 Sep 2015 Launched for Hepatitis B (Prevention) in South Korea (IV)
  • 08 Dec 2013 SK Chemicals completes enrolment in its phase III trial in Hepatitis B (prevention) in South Korea (NCT01513850)
  • 01 Oct 2010 Phase-III clinical trials in Hepatitis B (prevention) in South Korea (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top